Answers are grounded in this paper and cite their sources.
Extrarenal malignant rhabdoid tumour (MRT) is an aggressive cancer of infancy. Almost all reported survivors received multimodal therapy. An infant girl underwent excision of a congenital right cheek tumour at six weeks of age and of a metastatic submental lymph node shortly before six months. The primary resection had involved margins. External pathology review found loss of nuclear INI1 and diagnosed MRT, while acknowledging overlap with epithelioid sarcoma (ES). The treating team adopted MRT as its working diagnosis. A sarcoma conference recommended intensive chemotherapy and radiotherapy. The treating hospital could not safely deliver this regimen or provide the supportive care it required. After oncology consultation, the team and parents decided to withhold adjuvant therapy. In cooperative-group trials, patients with node-positive ES were also assigned chemotherapy and radiotherapy. The hospital's limitations would therefore probably have applied under either diagnosis. Seven years after surgery alone, the child has no clinical evidence of disease. This unusual outcome requires cautious interpretation because the tumour classification remains uncertain and follow-up has relied on clinical examination. This single case does not support withholding adjuvant therapy.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: